These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 23481247)

  • 1. Mutational analysis of the internal membrane proximal domain of the HIV glycoprotein C-terminus.
    Pfeiffer T; Erkelenz S; Widera M; Schaal H; Bosch V
    Virology; 2013 May; 440(1):31-40. PubMed ID: 23481247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and initial characterization of protein entities consisting of the HIV glycoprotein cytoplasmic C-terminal domain alone.
    Pfeiffer T; Ruppert T; Schaal H; Bosch V
    Virology; 2013 Jun; 441(1):85-94. PubMed ID: 23562537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The strength of the HIV-1 3' splice sites affects Rev function.
    Kammler S; Otte M; Hauber I; Kjems J; Hauber J; Schaal H
    Retrovirology; 2006 Dec; 3():89. PubMed ID: 17144911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Lethality and Loss of Env Protein Expression Induced by Single Synonymous Substitutions in the Virus Genome Intronic-Splicing Silencer.
    Jordan-Paiz A; Nevot M; Lamkiewicz K; Lataretu M; Franco S; Marz M; Martinez MA
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
    Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
    Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential control of human immunodeficiency virus type 1 asp expression by alternative splicing in the upstream untranslated region.
    Barbagallo MS; Birch KE; Deacon NJ; Mosse JA
    DNA Cell Biol; 2012 Jul; 31(7):1303-13. PubMed ID: 22455394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
    González SA; Affranchino JL
    Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
    Celma CC; Paladino MG; González SA; Affranchino JL
    Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
    Bhat GV; Temin HM
    Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
    Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hnRNP E1 and E2 have distinct roles in modulating HIV-1 gene expression.
    Woolaway K; Asai K; Emili A; Cochrane A
    Retrovirology; 2007 Apr; 4():28. PubMed ID: 17451601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 resistance to the anti-HIV activity of a shRNA targeting a dual-coding region.
    Senserrich J; Pauls E; Armand-Ugón M; Clotet-Codina I; Moncunill G; Clotet B; Esté JA
    Virology; 2008 Mar; 372(2):421-9. PubMed ID: 18068205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sequence analysis of gag and env genes of HIV type 1 circulating in former blood donors of Fuyang city, Anhui province].
    Wang SH; Xing H; Wang JJ; Su B; Chen X; Quan Y; Zhao QB; Ruan YH; Xu JQ; Song YH; Shao YM
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1535-9. PubMed ID: 17785105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain.
    Bu Z; Ye L; Vzorov A; Taylor D; Compans RW; Yang C
    Virology; 2004 Oct; 328(1):62-73. PubMed ID: 15380359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping mutational effects along the evolutionary landscape of HIV envelope.
    Haddox HK; Dingens AS; Hilton SK; Overbaugh J; Bloom JD
    Elife; 2018 Mar; 7():. PubMed ID: 29590010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane fusion mediated by human immunodeficiency virus envelope glycoprotein.
    Melikyan GB
    Curr Top Membr; 2011; 68():81-106. PubMed ID: 21771496
    [No Abstract]   [Full Text] [Related]  

  • 20. Creation of the HIV-1 antisense gene
    Pavesi A; Romerio F
    Microbiol Spectr; 2024 Feb; 12(2):e0380223. PubMed ID: 38230940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.